Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Pulmonary insulin enters phase II

April 26, 1996

OT-5226: New antidiabetic from Otsuka

April 26, 1996

Amgen presents NESP

April 26, 1996

Three beta3-adrenoceptor agonists in preclinical stage at BMS

April 26, 1996

MTP inhibitor BMS-201038 in development for hyperlipidemia

April 26, 1996

Colestimide NDA filing imminent

April 26, 1996

Otsuka evaluates hypolipidemic agents

April 26, 1996

Sanofi Winthrop discovers potent ATP-citrate lyase inhibitor

April 26, 1996

NTE-122: Nissin Foods' ACAT inhibitor

April 26, 1996

FemPatch approval imminent in USA

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026